METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN.
D001491:Basophils; D035843:Biomedical Research; D002738:Chloroquine; D003913:Dextroamphetamine; D004358:Drug Therapy; D006636:Histamine Release; D006801:Humans; D006967:Hypersensitivity; D007958:Leukocyte Count; D008297:Male; D008407:Mast Cells; D008784:Methysergide; D008881:Migraine Disorders; D009640:Norethindrone; D010600:Pharmacology; D010919:Placebos; D014116:Toxicology; D014221:Triamcinolone
D010919:Placebos; D014221:Triamcinolone; D002738:Chloroquine; D009640:Norethindrone; D003913:Dextroamphetamine; D008784:Methysergide
BASOPHILS; CHLOROQUINE; CLINICAL RESEARCH; DEXTRO AMPHETAMINE; DRUG THERAPY; HISTAMINE LIBERATION; HYPERSENSITIVITY; LEUKOCYTE COUNT; MAST CELLS; METHYSERGIDE; MIGRAINE; NORETHINDRONE; PHARMACOLOGY; PLACEBOS; TOXICOLOGIC REPORT; TRIAMCINOLONE